Coronary Artery Spasm in Memory of Prof
暂无分享,去创建一个
[1] K. Channon,et al. Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership , 2022, Heart.
[2] C. Berry,et al. Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis , 2022, Journal of the American Heart Association.
[3] H. Shimokawa,et al. Isolated cardiac sarcoidosis associated with coronary vasomotion abnormalities: a case report , 2022, European heart journal. Case reports.
[4] Tomoki Sakaue,et al. Intracoronary ergonovine testing among 505 consecutive Japanese patients with angina-like chest pain and unobstructed coronary artery disease , 2022, Heart and Vessels.
[5] P. Damman,et al. Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm. , 2022, JACC. Cardiovascular interventions.
[6] V. Fuster,et al. A tribute to Attilio Maseri. , 2021, European heart journal.
[7] H. Shimokawa,et al. Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm. , 2021, Journal of visualized experiments : JoVE.
[8] G. Niccoli,et al. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. , 2021, Journal of the American College of Cardiology.
[9] F. Crea,et al. Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group , 2021, European heart journal.
[10] T. Shindo,et al. Prognostic Links Between OCT-Delineated Coronary Morphologies and Coronary Functional Abnormalities in Patients With INOCA. , 2021, JACC. Cardiovascular interventions.
[11] H. Shimokawa,et al. Pathophysiology and Diagnosis of Coronary Functional Abnormalities , 2021, European cardiology.
[12] H. Shimokawa,et al. Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction , 2021, European cardiology.
[13] J. Kastrup,et al. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study. , 2020, European heart journal.
[14] L. Lerman,et al. Association of Coronary Microvascular Endothelial Dysfunction with Vulnerable Plaque Characteristics in Early Coronary Atherosclerosis. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[15] Sanjiv J. Shah,et al. Association of Coronary Microvascular Dysfunction with Heart Failure Hospitalizations and Mortality in Heart Failure with Preserved Ejection Fraction - a follow-up in the PROMIS-HFpEF study. , 2020, Journal of cardiac failure.
[16] A. Baumbach,et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. , 2020, European heart journal.
[17] U. Sechtem,et al. Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries. , 2020, European heart journal. Acute cardiovascular care.
[18] A. Chieffo,et al. Gender-Related Differences in Clinical Presentation and Angiographic Findings in Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA): A Single-Center Observational Registry , 2020, International Journal of Angiology.
[19] V. Murthy,et al. Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta‐Analysis of Aggregate Data , 2020, Journal of the American Heart Association.
[20] A. Quyyumi,et al. Soluble Urokinase‐Type Plasminogen Activator Receptor and High‐Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease , 2020, Journal of the American Heart Association.
[21] T. Shindo,et al. Marked Impairment of Endothelium-Dependent Digital Vasodilatations in Patients With Microvascular Angina , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[22] D. Holmes,et al. Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003-2016. , 2020, JAMA network open.
[23] T. Shindo,et al. Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia. , 2019, International journal of cardiology.
[24] S. Miyata,et al. Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease. , 2019, Journal of the American College of Cardiology.
[25] F. Crea,et al. Clinical outcomes in patients with primary stable microvascular angina: is the Jury still out? , 2019, European heart journal. Quality of care & clinical outcomes.
[26] U. Sechtem,et al. Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA) , 2019, Clinical Research in Cardiology.
[27] E. Prescott,et al. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. , 2018, European heart journal.
[28] A. Quyyumi,et al. Peripheral Microvascular Function Reflects Coronary Vascular Function. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[29] Christopher J. Rush,et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.
[30] Gabriel A. Koepp,et al. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial , 2018, JAMA.
[31] R. de Caterina,et al. Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis , 2018, European heart journal.
[32] T. Shindo,et al. Coronary Adventitial and Perivascular Adipose Tissue Inflammation in Patients With Vasospastic Angina. , 2018, Journal of the American College of Cardiology.
[33] G. Niccoli,et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests , 2017, European heart journal.
[34] E. Prescott,et al. Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries. , 2017, Journal of the American College of Cardiology.
[35] P. Libby,et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.
[36] H. Shimokawa,et al. Endothelial dysfunction and vascular disease – a 30th anniversary update , 2017, Acta physiologica.
[37] Kenta Ito,et al. Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries , 2016, European heart journal.
[38] Kenta Ito,et al. Enhanced Adventitial Vasa Vasorum Formation in Patients With Vasospastic Angina: Assessment With OFDI. , 2016, Journal of the American College of Cardiology.
[39] H. Shimokawa,et al. RhoA/Rho-Kinase in the Cardiovascular System. , 2016, Circulation research.
[40] H. Shimokawa,et al. Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[41] Gabriel A. Koepp,et al. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. , 2015, The New England journal of medicine.
[42] R Jay Widmer,et al. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. , 2015, JACC. Cardiovascular interventions.
[43] Ryotaro Yamada,et al. Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease , 2015, Circulation.
[44] S. Miyata,et al. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. , 2015, European heart journal.
[45] H. Shimokawa. 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside. , 2014, European heart journal.
[46] Deepak L. Bhatt,et al. Nonobstructive coronary artery disease and risk of myocardial infarction. , 2014, JAMA.
[47] O. Rimoldi,et al. Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes , 2014, Circulation.
[48] F. Crea,et al. Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .
[49] J. Kaski,et al. Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.
[50] Filippo Crea,et al. Coronary microvascular dysfunction. , 2013, The New England journal of medicine.
[51] Carl J Pepine,et al. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. , 2013, American heart journal.
[52] K. Sakamoto,et al. Microvascular Coronary Artery Spasm Presents Distinctive Clinical Features With Endothelial Dysfunction as Nonobstructive Coronary Artery Disease , 2012, Journal of the American Heart Association.
[53] Erik Jørgensen,et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.
[54] J. Kaski,et al. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). , 2012, Journal of the American College of Cardiology.
[55] Kenta Ito,et al. Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment. , 2011, Journal of the American College of Cardiology.
[56] Pamela S Douglas,et al. Low diagnostic yield of elective coronary angiography. , 2010, The New England journal of medicine.
[57] Kenta Ito,et al. Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. , 2009, Journal of the American College of Cardiology.
[58] Carl J Pepine,et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.
[59] A. Maseri,et al. Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[60] H. Shimokawa,et al. Myocardial ischemia: current concepts and future perspectives. , 2008, Journal of cardiology.
[61] L. Shaw,et al. Impact of Ethnicity and Gender Differences on Angiographic Coronary Artery Disease Prevalence and In-Hospital Mortality in the American College of Cardiology–National Cardiovascular Data Registry , 2008, Circulation.
[62] Hidezo Mori,et al. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo. , 2007, Journal of the American College of Cardiology.
[63] Hidezo Mori,et al. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo. , 2006, American journal of physiology. Heart and circulatory physiology.
[64] Carl J Pepine,et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. , 2006, Journal of the American College of Cardiology.
[65] K. Sunagawa,et al. Coronary Microvascular Dysfunction in Patients With Microvascular Angina: Analysis by TIMI Frame Count , 2005, Journal of cardiovascular pharmacology.
[66] H. Shimokawa,et al. Usefulness of Fasudil, a Rho-kinase Inhibitor, to Treat Intractable Severe Coronary Spasm after Coronary Artery Bypass Surgery , 2004, Journal of cardiovascular pharmacology.
[67] K. Smith,et al. Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results From the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.
[68] Yasuo Ogasawara,et al. Hydrogen Peroxide, an Endogenous Endothelium-Derived Hyperpolarizing Factor, Plays an Important Role in Coronary Autoregulation In Vivo , 2003, Circulation.
[69] Takashi Saito,et al. Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles , 2003, Circulation research.
[70] A. Takeshita,et al. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. , 2002, Journal of the American College of Cardiology.
[71] A. Takeshita,et al. Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. , 2001, International journal of cardiology.
[72] H Shimokawa,et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. , 2000, The Journal of clinical investigation.
[73] N Reichek,et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. , 1999, Journal of the American College of Cardiology.
[74] A. Takeshita,et al. Angina pectoris caused by coronary microvascular spasm , 1998, The Lancet.
[75] A. Takeshita,et al. Importance of endothelium-derived hyperpolarizing factor in human arteries. , 1997, The Journal of clinical investigation.
[76] R Busse,et al. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. , 1996, Circulation.
[77] M. Fujishima,et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. , 1996, Journal of cardiovascular pharmacology.
[78] A. Takeshita,et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. , 1996, The Journal of clinical investigation.
[79] A. Rebuzzi,et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.
[80] F. Crea,et al. Inappropriate Constriction of Small Coronary Vessels as a Possible Cause of a Positive Exercise Test Early After Successful Coronary Angioplasty , 1991, Circulation.
[81] A. Maseri,et al. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. , 1991, The New England journal of medicine.
[82] F. Crea,et al. Mechanisms of angina pectoris in syndrome X. , 1991, Journal of the American College of Cardiology.
[83] F. Crea,et al. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. , 1990, The New England journal of medicine.
[84] A. Maseri,et al. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. , 1989, The American journal of cardiology.
[85] H. Kennedy,et al. Impaired coronary vasodilator reserve in the immediate postcoronary angioplasty period: analysis of coronary artery flow velocity indexes and regional cardiac venous efflux. , 1989, Journal of the American College of Cardiology.
[86] R. Kerwin,et al. CORONARY ARTERY INFUSION OF NEUROPEPTIDE Y IN PATIENTS WITH ANGINA PECTORIS , 1987, The Lancet.
[87] A. Gallino,et al. ROLE OF HEART RATE IN PATHOPHYSIOLOGY OF CHRONIC STABLE ANGINA , 1984, The Lancet.
[88] S. Chierchia,et al. MYOCARDIAL ISCHAEMIA DURING DAILY LIFE IN PATIENTS WITH STABLE ANGINA: ITS RELATION TO SYMPTOMS AND HEART RATE CHANGES , 1983, The Lancet.
[89] K. Tanaka,et al. Coronary artery spasm induced in atherosclerotic miniature swine. , 1983, Science.
[90] A. Maseri. THE CHANGING FACE OF ANGINA PECTORIS: PRACTICAL IMPLICATIONS , 1983, The Lancet.
[91] S. Chierchia,et al. Coronary artery spasm: demonstration, definition, diagnosis, and consequences. , 1982, Progress in cardiovascular diseases.
[92] A. Maseri. The revival of coronary spasm. , 1981, The American journal of medicine.
[93] S. Chierchia,et al. Coronary vasospasm in ischemic heart disease. , 1980, Chest.
[94] A. Maseri,et al. Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit. , 1979, British heart journal.
[95] S. Chierchia,et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.
[96] S. Chierchia,et al. "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. , 1978, The American journal of cardiology.
[97] S. Chierchia,et al. Coronary artery spasm--diagnostic and therapeutic implications. , 1978, American heart journal.
[98] A. Maseri,et al. CORONARY VASOSPASM IN ANGINA PECTORIS , 1977, The Lancet.
[99] A. Maseri. Pathophysiologic studies of the pulmonary and coronary circulations in man. , 1976, The American journal of cardiology.
[100] A. Maseri,et al. Transient Transmural Reduction of Myocardial Blood Flow, Demonstrated by Thallium‐201 Scintigraphy, as a Cause of Variant Angina , 1976, Circulation.
[101] C. Marchesi,et al. Coronary Artery Spasm as a Cause of Acute Myocardial Ischemia in Man , 1975 .
[102] N. Krasnow,et al. Myocardial lactate and pyruvate metabolism. , 1962, The Journal of clinical investigation.
[103] R. Daley. The Autonomic Nervous System in its Relation to Some Forms of Heart and Lung Disease* , 1957 .
[104] OUP accepted manuscript , 2022, Cardiovascular Research.
[105] H. Shimokawa. Coronary Vasomotion Abnormalities , 2021 .
[106] Hiroaki Shimokawa,et al. International standardization of diagnostic criteria for microvascular angina. , 2018, International journal of cardiology.
[107] Ornella Rimoldi,et al. Coronary microvascular dysfunction: mechanisms and functional assessment , 2015, Nature Reviews Cardiology.
[108] Hiroaki Shimokawa,et al. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. , 2003, Journal of the American College of Cardiology.
[109] A. Maseri,et al. Endothelin‐1 Is a Potent Constrictor in Conductive and Resistive Coronary Arteries , 1989, Journal of cardiovascular pharmacology.